Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-022833
Filing Date
2020-08-18
Accepted
2020-08-18 21:29:53
Documents
2
Period of Report
2020-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1557
2 EX-24 DOCUMENT attachment1.htm EX-24 3767
  Complete submission text file 0000899243-20-022833.txt   6744
Mailing Address C/O SYNERGY PHARMACEUTICALS INC. 420 LEXINGTON AVE NEW YORK NY 10020
Business Address
Sender Gary (Reporting) CIK: 0001659085 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39450 | Film No.: 201115179

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations